Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 5/20 | 0.55 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.53 |
| ▸ | APLNR | P35414 | 2/20 | 0.52 |
| ▸ | MC4R | P32245 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
| ▸ | TACR1 | P25103 | 1/20 | 0.50 |
| ▸ | GHSR | Q92847 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29655724 | 0.94 | F2 (0.60) | F2C5AR1APLNRMC4RTACR1 | |
| SCHEMBL29381047 | 0.91 | C5AR1 (0.62) | F2C5AR1APLNRTACR1 | |
| SCHEMBL30904766 | 0.90 | C5AR1 (0.65) | F2C5AR1MC4RTACR1 | |
| SCHEMBL29655661 | 0.90 | C5AR1 (0.63) | C5AR1TACR1 | |
| SCHEMBL31356966 | 0.89 | C5AR1 (0.61) | C5AR1APLNRMC4RGHSR | |
| SCHEMBL30355006 | 0.89 | C5AR1 (0.64) | F2C5AR1APLNROPRM1TACR1 | |
| SCHEMBL30969039 | 0.89 | APLNR (0.55) | F2C5AR1APLNR | |
| SCHEMBL30617831 | 0.89 | F2 (0.58) | F2C5AR1APLNROPRM1OPRD1 | |
| SCHEMBL29531965 | 0.88 | SLC6A2 (0.50) | F2OPRM1OPRD1 | |
| SCHEMBL29756048 | 0.88 | C5AR1 (0.63) | F2C5AR1APLNRTACR1GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117106716-A | Method for culturing cells and kit and device for use in the method | 朱诺治疗学有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-116875635-A | Method, reagent cartridge, reagent and device for transduction | 朱诺治疗学有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-109071616-B | Streptavidin muteins and methods of use thereof | IBA股份有限公司 | 2023-09-19 | — | — | CN | claimed |
| CN-115605230-A | Enzymes for sialylation of glycans | 动量制药公司（US） | 2023-01-13 | — | — | CN | claimed |
| EP-4737561-A2 | PROCESSES FOR GENERATING ENGINEERED CELLS AND COMPOSITIONS THEREOF | Juno Therapeutics, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-12522660-B2 | Methods for selection and stimulation of cells and apparatus for same | C3S2 GMBH (DE) | 2026-01-13 | — | — | US | disclosed |
| US-20250237628-A1 | CELL SELECTION AND/OR STIMULATION DEVICES AND METHODS OF USE | JUNO THERAPEUTICS GMBH (DE) | 2025-07-24 | — | — | US | disclosed |
| US-20250019723-A1 | METHODS, KITS, AGENTS AND APPARATUSES FOR TRANSDUCTION | JUNO THERAPEUTICS GMBH (DE) | 2025-01-16 | — | — | US | disclosed |
| CN-117659145-B | Mutant protein S27V of streptavidin 27 th serine mutation and application thereof | 西南大学 | 2024-08-02 | — | — | CN | disclosed |
| CN-117264035-B | Mutant protein S27K of streptavidin 27 th serine mutation and application thereof | 西南大学 | 2024-05-14 | — | — | CN | disclosed |
| EP-4334341-A2 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | Juno Therapeutics GmbH (DE) | 2024-03-13 | — | — | EP | disclosed |
| CN-117659145-A | Mutant protein S27V of streptavidin 27 th serine mutation and application thereof | 西南大学 | 2024-03-08 | — | — | CN | disclosed |
| CN-115666751-A | Method for producing highly sialylated immunoglobulins | 动量制药公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-115605230-A | Enzymes for sialylation of glycans | 动量制药公司（US） | 2023-01-13 | — | — | CN | disclosed |
| US-11517627-B2 | Cell surface conjugates and related cell compositions and methods | JUNO THERAPEUTICS GMBH (DE) | 2022-12-06 | — | — | US | disclosed |
| WO-2022234009-A2 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | JUNO THERAPEUTICS GMBH (DE) | 2022-11-10 | — | — | WO | disclosed |
| CN-115261317-A | Method for culturing cells, and kit and apparatus for the same | 朱诺治疗学有限公司 | 2022-11-01 | — | — | CN | disclosed |
| EP-4051402-A1 | CELL SELECTION AND/OR STIMULATION DEVICES AND METHODS OF USE | Juno Therapeutics GmbH (DE) | 2022-09-07 | — | — | EP | disclosed |
| CN-114507274-A | Streptavidin mutein capable of reversibly binding biotin and application thereof | 西南大学 | 2022-05-17 | — | — | CN | disclosed |
| CN-114478726-A | Mutant protein with 27 th serine mutation of streptavidin and application thereof | 西南大学 | 2022-05-13 | — | — | CN | disclosed |